CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.203995
+0.00602 (3.04%)
At close: Jul 27, 2026
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $280.15 million as of July 28, 2026. Its market cap has decreased by -24.51% in one year.
Market Cap
280.15M
Enterprise Value
293.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
ChartMarket Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 280.15M, an increase of 4,959.10%. That is a compound annual growth rate of 20.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 280.15M | -21.22% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 520.52M |
| Glorywin Entertainment Group | 359.76M |
| Northwest Biotherapeutics | 289.81M |
| Vaxart | 119.44M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 85.98M |
| BioStem Technologies | 71.08M |
| Nuo Therapeutics | 49.38M |